← Back to headlines
Celularity Finalizes Strategic License Deal for Biomaterials Portfolio
Celularity has successfully secured a strategic license deal for its biomaterials portfolio, with the agreement potentially valued at up to $35 million.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Widespread Russian Drone Strikes Hit Ukrainian Infrastructure and Civilian Areas
30m ago
Fed Chair Warsh Signals Potential Rate Hike Amid Persistent Inflation Concerns
31m ago
Google Revises European Spam Policy Amid EU Antitrust Pressure
47m ago
Deliveroo Raises Italian Courier Wages Following Exploitation Allegations
53m ago